Screening for mutations in the MECP2 (Rett syndrome) gene in Gilles de la Tourette syndrome

Archives of Neurology

Volumn 60, Issue 4, 2003, Pages 502-503

  Rosa, Alberto L ^a,b,d   Jankovic, Joseph ^a   Ashizawa, Tetsuo ^a,b,c,e  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^d INSTITUTO DE INVESTIGACIÓN MÉDICA MERCEDES Y MARTÍN FERREYRA   (Argentina)

^e University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME 11Q; CHROMOSOME 18Q; CHROMOSOME 7Q; GENE; GENE LOCUS; GENETIC LINKAGE; GENETIC SCREENING; GILLES DE LA TOURETTE SYNDROME; HUMAN; MECP2 GENE; PRIORITY JOURNAL; RETT SYNDROME;

CHROMOSOMAL PROTEINS, NON-HISTONE; DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; GENETIC SCREENING; GENOTYPE; HUMANS; MALE; METHYL-CPG-BINDING PROTEIN 2; MUTATION; PHENOTYPE; POLYMERASE CHAIN REACTION; REPRESSOR PROTEINS; RETT SYNDROME; TOURETTE SYNDROME;

EID: 0037390312     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.60.4.502     Document Type: Article

References (29)

1. Jankovic J. Tourette's syndrome. N Engl J Med. 2001;345:1184-1192.
2. The Tourette Syndrome Association International Consortium on Genetics. A complete genome screen in sib-pairs affected by Gilles de la Tourette syndrome. Am J Hum Genet. 1999;65:1428-1436.
3. Hanna PA, Janjua FN, Contant CF, Jankovic J. Bilineal transmission in Tourette syndrome. Neurology. 1999;53:813-818.
4. Cohen DJ, Jankovic J, Goetz GG, eds. Tourette syndrome. Adv Neurol. 2001;85:1-400.
5. Merette C, Brassard A, Potvin A, et al. Significant linkage for Tourette syndrome in a large French Canadian family. Am J Hum Genet. 2000;67:1008-1013.
6. Comings DE. The genetics of Rett syndrome: the consequences of a disorder where every case is a new mutation. Am J Med Genet Suppl. 1986;1:383-388.
7. Petek E, Windpassinger C, Vincent JB, et al. Disruption of a novel gene (IMMP2L) by a breakpoint in 7q31 associated with Tourette syndrome. Am J Hum Genet. 2001;68:848-858.
8. Boghosian-Sell L, Comings DE, Overhauser J. Tourette syndrome in a pedigree with a 7;18 translocation:identification of a YAC spanning the translocation breakpoint at 18q22.3. Am J Hum Genet. 1996;59:999-1005.
9. Zhang H, Leckman JF, Pauls DL, et al. Genomewide scan of hoarding in sib pairs in which both sibs have Gilles de la Tourette syndrome. Am J Hum Genet. 2002;70:896-904.
10. Freeman RD, Fast DK, Burd L, et al. An international perspective on Tourette syndrome: selected findings from 3,500 individuals in 22 countries. Dev Med Child Neurol. 2000;42:436-447.
11. Comings DE, Comings BG. Evidence of an X-linked modifier gene affecting the expression of Tourette syndrome and its relevance to the increased frequency of speech, cognitive, and behavioral disorders in males. Proc Natl Acad Sci USA. 1986;83:2551-2555.
12. Hagberg B, Aicardi J, Dias K, et al. A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: report of 35 cases. Ann Neurol. 1983;14:471-479.
13. Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet. 1999;23:185-188.
14. Leonard H, Silberstein J, Falk R, et al. Occurrence of Rett syndrome in boys. J Child Neurol. 2001;16:333-338.
15. Schwartzman JS, Bernardino A, Nishimura A, et al. Rett syndrome in a boy with a 47,XXY karyotype confirmed by a rare mutation in the MECP2 gene. Neuropediatrics. 2001;32:162-164.
16. Orrico A, Lam C, Galli L, et al. MECP2 mutation in male patients with non-specific X-linked mental retardation. FEBS Lett. 2000;481:285-288.
17. Meloni I, Bruttini M, Longo I, et al. A mutation in the Rett syndrome gene, MECP2, causes X-linked mental retardation and progressive spasticity in males. Am J Hum Genet. 2000;67:982-985.
18. Couvert P, Bienvenu T, Aquaviva C, et al. MECP2 is highly mutated in X-linked mental retardation. Hum Mol Genet. 2001;10:941-946.
19. Watson P, Black G, Ramsden S, et al. Angelman syndrome phenotype associated with mutations in MECP2, a gene encoding a methyl CpG binding protein. J Med Genet. 2001;38:224-228.
20. Imessaoudene B, Bonnefont JP, Royer G, et al. MECP2 mutation in non-fatal, non-progressive encephalopathy in a male. J Med Genet. 2001;38:171-174.
21. Villard L, Kpebe A, Cardoso C, et al. Two affected boys in a Rett syndrome family: clinical and molecular findings. Neurology. 2000;55:1188-1193.
22. Swerdlow NR, Young AB. Neuropathology in Tourette syndrome: an update. Adv Neurol. 2001;85:179-196.
23. Jellinger K, Armstrong D, Zoghbi HY, Percy AK. Neuropathology of Rett syndrome. Acta Neuropathol. 198876:142-158.
24. Simonic I, Gericke GS, Lippert M, et al. Additional clinical and cytogenetic findings associated with Rett syndrome. Am J Med Genet. 1997;74:331-337.
25. Zappella M. Early-onset Tourette syndrome with reversible autistic behaviour: a dysmaturational disorder. Eur Child Adolesc Psychiatry. 2002;11:18-23.
26. The Tourette Syndrome Classification Study Group. Definitions and classification of tic disorders. Arch Neurol. 1993;50:1013-1016.
27. Buyse IM, Fang P, Hoon KT, et al. Diagnostic testing for Rett syndrome by DHPLC and direct sequencing analysis of the MECP2 gene: identification of several novel mutations and polymorphisms. Am J Hum Genet. 2000;67:1428-1436.
28. Amir RE, Van den Veyver IB, Wan M, et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet. 1999;23:185-188.
29. Hampson K, Woods CG, Latif F, et al. Mutations in the MECP2 gene in a cohort of girls with Rett syndrome. J Med Genet. 2000;37:610-612.